Announced
Completed
Financials
Tags
Acquisition
Private
Single Bidder
Friendly
CBD products
United States
Majority
Completed
Medical Supplies
Cross Border
Synopsis
Aurora Cannabis, a Canadian cannabinoids company, completed the acquisition of Reliva, a seller of hemp-derived CBD products in the US for $85m. "We are pleased to have closed the Reliva transaction ahead of schedule. The partnership between Aurora and Reliva is expected to create a market leading international cannabinoid platform that we believe can deliver robust revenue and profitable growth," Michael Singer, Aurora Executive Chairman and Interim CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.